GSK PLC ADR

ISIN US37733W2044

 | 

WKN A3DMHS

Market cap (in EUR)
87,219 m
Country
United Kingdom
Sector
Healthcare
Dividend yield
3.46%
 

Overview

Description

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
Show more Show less
Healthcare Biopharmaceuticals Other Biopharmaceuticals United Kingdom

Financials

Key metrics

Market capitalisation, EUR 87,219 m
EPS, EUR 3.35
P/B ratio 4.3
P/E ratio 13.0
Dividend yield 3.46%

Income statement (2025)

Revenue, EUR 38,162 m
Net income, EUR 6,677 m
Profit margin 17.50%

What ETF is GSK PLC ADR in?

There are 2 ETFs which contain GSK PLC ADR. All of these ETFs are listed in the table below. The ETF with the largest weighting of GSK PLC ADR is the Goldman Sachs Alpha Enhanced Europe Equity Active UCITS ETF EUR (Acc).
ETF Weight Investment focus Fund size (in m EUR)
Goldman Sachs Alpha Enhanced Europe Equity Active UCITS ETF EUR (Acc) 1.14%
Equity
Europe
Social/Environmental
444
Goldman Sachs Alpha Enhanced World Equity Active UCITS ETF CLASS USD (Acc) 0.37%
Equity
World
Social/Environmental
164
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.